Thursday, June 12, 2025

Mother-to-Baby COVID Transmission Remains Low, Research Reveals

Similar articles

A recent comprehensive study sheds light on the transmission rates of SARS-CoV-2 from mothers to their newborns, revealing a surprisingly low prevalence. The investigation encompassed over 200 observational studies, providing a robust analysis of vertical transmission dynamics across various global regions.

Transmission Rates and Influencing Factors

The research identified an overall vertical transmission rate of 4%, although this figure exhibited significant variability depending on several factors. Notably, higher transmission rates were observed in lower-income regions and among cesarean deliveries. These disparities suggest that socioeconomic and medical practices play crucial roles in the transmission process.

Subscribe to our newsletter

Antibody Presence and Breast Milk Findings

In examining the presence of antibodies, the study found that neonates frequently developed SARS-CoV-2-specific IgG antibodies, whereas IgM antibodies were less commonly detected. Additionally, the occurrence of maternal SARS-CoV-2 in breast milk was rare, indicating that breastfeeding may pose a minimal risk of transmitting the virus to the infant.

  • Vertical transmission occurs in a small percentage of cases, emphasizing its rarity.
  • Higher transmission rates in low-income areas highlight the need for improved healthcare infrastructure.
  • Cesarean deliveries are associated with increased transmission risk compared to vaginal births.
  • Presence of IgG antibodies in newborns suggests some level of passive immunity.

This study underscores the infrequency of mother-to-child transmission of COVID-19, offering reassurance to expectant mothers. However, the identified disparities in transmission rates based on income and delivery methods call for targeted interventions to enhance maternal and neonatal healthcare, especially in underserved regions. Future research should focus on longitudinal studies to better understand the long-term implications of neonatal antibody presence and to develop strategies that mitigate transmission risks during childbirth.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article